Partners4Access
Partners4Access (P4A) is a global consultancy specializing in market access for orphan drugs, cell and gene therapies. Founded in 2015 and based in the Netherlands, P4A offers bespoke solutions supporting commercialization journeys from clinical development to full maturity. Their services include access strategy, price optimization, value communication, and digital solutions such as AI-powered tools to optimize access processes. P4A is recognized for its expertise in rare diseases and advanced therapies, partnering with clients worldwide to drive sustainable patient access while balancing fair returns for manufacturers and affordability for healthcare systems. The company has won multiple global awards for excellence in orphan drug and gene therapy access and maintains a passionate, expert team dedicated to rare disease patient outcomes.
Partners4Access
Partners4Access (P4A) is a global consultancy specializing in market access for orphan drugs, cell and gene therapies. Founded in 2015 and based in the Netherlands, P4A offers bespoke solutions supporting commercialization journeys from clinical development to full maturity. Their services include access strategy, price optimization, value communication, and digital solutions such as AI-powered tools to optimize access processes. P4A is recognized for its expertise in rare diseases and advanced therapies, partnering with clients worldwide to drive sustainable patient access while balancing fair returns for manufacturers and affordability for healthcare systems. The company has won multiple global awards for excellence in orphan drug and gene therapy access and maintains a passionate, expert team dedicated to rare disease patient outcomes.